Profile | GDS4284 / 230651_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1603.02 | 81 |
GSM687648 | Patient 402 control | 888.972 | 72 |
GSM687653 | Patient 403 control | 1799.82 | 83 |
GSM687658 | Patient 404 control | 1856.11 | 83 |
GSM687663 | Patient 411 control | 2650.22 | 87 |
GSM687668 | Patient 422 control | 2049.02 | 84 |
GSM687673 | Patient 424 control | 2214.35 | 85 |
GSM687678 | Patient 425 control | 1595.17 | 80 |
GSM687683 | Patient 427 control | 2178.25 | 85 |
GSM687688 | Patient 428 control | 2686.92 | 88 |
GSM687695 | Patient 441 control | 1454.66 | 81 |
GSM687699 | Patient 443 control | 1391.82 | 79 |
GSM687704 | Patient 444 control | 2783.63 | 88 |
GSM687707 | Patient 448 control | 1649.07 | 82 |
GSM687712 | Patient 449 control | 1476.38 | 80 |
GSM687719 | Patient 450 control | 1574.84 | 81 |
GSM687724 | Patient 451 control | 2432.54 | 87 |
GSM687728 | Patient 452 control | 2090.39 | 85 |
GSM687646 | Patient 401 treated 24h | 2013.43 | 84 |
GSM687649 | Patient 402 treated 24h | 1233.16 | 77 |
GSM687665 | Patient 411 treated 24h | 2245.13 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 1284.23 | 77 |
GSM687667 | Patient 411 treated 4 weeks | 1770.41 | 82 |
GSM687670 | Patient 422 treated 24h | 1800.74 | 82 |
GSM687671 | Patient 422 treated 4 weeks | 1624.25 | 81 |
GSM687654 | Patient 403 treated 24h | 2472.92 | 86 |
GSM687675 | Patient 424 treated 24h | 1456.54 | 79 |
GSM687685 | Patient 427 treated 24h | 2339.66 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 1863.69 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 3449.85 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 1787.41 | 82 |
GSM687692 | Patient 428 treated 4h | 2203.32 | 85 |
GSM687716 | Patient 449 treated 4h | 2141.32 | 85 |
GSM687722 | Patient 450 treated 4h | 1453.69 | 80 |
GSM687680 | Patient 425 treated 24h | 2050.51 | 84 |
GSM687690 | Patient 428 treated 24h | 1993.28 | 84 |
GSM687700 | Patient 443 treated 24h | 1558.19 | 81 |
GSM687705 | Patient 444 treated 24h | 3311.03 | 90 |
GSM687714 | Patient 449 treated 24h | 1481.49 | 80 |
GSM687721 | Patient 450 treated 24h | 1229.22 | 77 |
GSM687682 | Patient 425 treated 4 weeks | 3095.97 | 89 |
GSM687694 | Patient 428 treated 4 weeks | 1964.35 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1467.27 | 79 |
GSM687718 | Patient 449 treated 4 weeks | 2179.61 | 85 |
GSM687723 | Patient 450 treated 4 weeks | 1580.6 | 81 |
GSM687661 | Patient 404 treated 4h | 1384.8 | 79 |
GSM687710 | Patient 448 treated 4h | 1838.2 | 83 |
GSM687726 | Patient 451 treated 4h | 2847.74 | 88 |
GSM687730 | Patient 452 treated 4h | 3583.88 | 92 |
GSM687660 | Patient 404 treated 24h | 1238.12 | 79 |
GSM687697 | Patient 441 treated 24h | 2005.82 | 85 |
GSM687709 | Patient 448 treated 24h | 1767.03 | 82 |
GSM687725 | Patient 451 treated 24h | 2893.69 | 89 |
GSM687729 | Patient 452 treated 24h | 1347.93 | 80 |
GSM687727 | Patient 451 treated 4 weeks | 4664.82 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 2343.81 | 86 |